Evaluation and Initial Management of Acute Kidney Injury
Authors:
- Jonathan HimmelfarbJHJonathan Himmelfarb
- Michael JoannidisMJMichael Joannidis
- Bruce MolitorisBMBruce Molitoris
- Miet SchietzMSMiet Schietz
- Mark D. OkusaMOMark D. Okusa
- David WarnockDWDavid Warnock
- Franco LaghiFLFranco Laghi
- Stuart L. GoldsteinSGStuart L. Goldstein
- Richard PrielippRPRichard Prielipp
- Chirag R. ParikhCPChirag R. Parikh
- Neesh PannuNPNeesh Pannu
- Suzana M. LoboSLSuzana M. Lobo
Open Access
- 1 July 2008
- journal article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 3 (4) , 962-967
Abstract
The evaluation and initial management of patients with acute kidney injury (AKI) should include: (1) an assessment of the contributing causes of the kidney injury, (2) an assessment of the clinical course including comorbidities, (3) a careful assessment of volume status, and (4) the institution of appropriate therapeutic measures designed to reverse or prevent worsening of functional or structural kidney abnormalities. The initial assessment of patients with AKI classically includes the differentiation between prerenal, renal, and postrenal causes. The differentiation between so-called “prerenal” and “renal” causes is more difficult, especially because renal hypoperfusion may coexist with any stage of AKI. Using a modified Delphi approach, the multidisciplinary international working group, generated a set of testable research questions. Key questions included the following: Is there a difference in prognosis between volume-responsive and volume-unresponsive AKI? Are there biomarkers whose patterns (dynamic changes) predict the severity and recovery of AKI (maximal stage of AKI, need for RRT, renal recovery, mortality) and guide therapy? What is the best biomarker to assess prospectively whether AKI is volume responsive? What is the best biomarker to assess the optimal volume status in AKI patients? In evaluating the current literature and ongoing studies, it was thought that the answers to the questions posed herein would improve the understanding of AKI, and ultimately patient outcomes.Keywords
This publication has 52 references indexed in Scilit:
- Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trialAmerican Heart Journal, 2007
- Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL)Circulation, 2007
- Meta-analysis of frusemide to prevent or treat acute renal failureBMJ, 2006
- Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair—a randomized controlled trialNephrology Dialysis Transplantation, 2006
- A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients*Critical Care Medicine, 2006
- Acute renal failureThe Lancet, 2005
- Renal sonography: Can it be used more selectively in the setting of an elevated serum creatinine level?American Journal of Kidney Diseases, 1997
- The effects of norepinephrine on hemodynamics and renal function in severe septic shock statesIntensive Care Medicine, 1993
- Prerenal Failure: A Deleterious Shift from Renal Compensation to DecompensationNew England Journal of Medicine, 1988
- The FENa test. Use in the differential diagnosis of acute renal failureJAMA, 1976